Impact of Oral Antipsychotic Medication Adherence on Healthcare Resource Utilization Among Schizophrenia Patients with Medicare Coverage
Authors:
- 10 August 2013
- journal article
- research article
- Published by Springer Nature in Community Mental Health Journal
- Vol. 49 (6) , 625-629
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Adherence to oral second‐generation antipsychotic medications in patients with schizophrenia and bipolar disorder: physicians’ perceptions of adherence vs. pharmacy claimsInternational Journal Of Clinical Practice, 2012
- Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherencePatient Preference and Adherence, 2011
- The cost of relapse and the predictors of relapse in the treatment of schizophreniaBMC Psychiatry, 2010
- Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior ResponseThe Journal of Clinical Psychiatry, 2009
- Improving Quality And Diffusing Best Practices: The Case Of SchizophreniaHealth Affairs, 2009
- Is Schizophrenia a Syndrome of Accelerated Aging?Schizophrenia Bulletin, 2008
- Outpatient Antipsychotic Treatment and Inpatient Costs of SchizophreniaSchizophrenia Bulletin, 2007
- Mortality among persons with schizophrenia in Sweden: An epidemiological studyNordic Journal of Psychiatry, 2007
- Patterns and Quality of Treatment for Patients With Schizophrenia in Routine Psychiatric PracticePsychiatric Services, 2005
- Late-Onset Schizophrenia and Very-Late-Onset Schizophrenia-Like Psychosis: An International ConsensusAmerican Journal of Psychiatry, 2000